4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001628280-22-005795
Options or other derivatives
- Chief Medical Officer acquired 170,016 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ruffner Katherine L Chief Medical Officer | 2022-03-09 | Grant or award · Stock Options | +170,016 | 370,016 | D | ||
Loading xslF345X03/wf-form4_164695574769782.xml…